454 related articles for article (PubMed ID: 16397167)
1. Methylenetetrahydrofolate reductase polymorphisms and homocysteine-lowering effect of vitamin therapy in Singaporean stroke patients.
Ho GY; Eikelboom JW; Hankey GJ; Wong CR; Tan SL; Chan JB; Chen CP
Stroke; 2006 Feb; 37(2):456-60. PubMed ID: 16397167
[TBL] [Abstract][Full Text] [Related]
2. Ethnicity does not affect the homocysteine-lowering effect of B-vitamin therapy in Singaporean stroke patients.
Kasiman K; Eikelboom JW; Hankey GJ; Lee SP; Lim JP; Lee JH; Chang HM; Wong MC; Chen CP
Stroke; 2009 Jun; 40(6):2209-11. PubMed ID: 19372453
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
4. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of B vitamins in lowering homocysteine in older men: maximal effects for those with B12 deficiency and hyperhomocysteinemia.
Flicker L; Vasikaran SD; Thomas J; Acres JM; Norman P; Jamrozik K; Hankey GJ; Almeida OP
Stroke; 2006 Feb; 37(2):547-9. PubMed ID: 16373648
[TBL] [Abstract][Full Text] [Related]
7. [Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHRF) genotype].
González Ordóñez AJ; Medina Rodríguez JM; Fernández Alvarez CR; Sánchez García J; Fernández Carreira JM; Alvarez Martínez MV; Coto García E
Med Clin (Barc); 2000 Jan; 114(1):7-12. PubMed ID: 10782453
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial].
Sánchez Alvarez JE; Pérez Tamajón L; Hernández D; Alvarez González A; Delgado P; Lorenzo V
Nefrologia; 2005; 25(3):288-96. PubMed ID: 16053010
[TBL] [Abstract][Full Text] [Related]
9. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study.
Dekou V; Whincup P; Papacosta O; Ebrahim S; Lennon L; Ueland PM; Refsum H; Humphries SE; Gudnason V
Atherosclerosis; 2001 Feb; 154(3):659-66. PubMed ID: 11257267
[TBL] [Abstract][Full Text] [Related]
10. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.
Kölling K; Ndrepepa G; Koch W; Braun S; Mehilli J; Schömig A; Kastrati A
Am J Cardiol; 2004 May; 93(10):1201-6. PubMed ID: 15135689
[TBL] [Abstract][Full Text] [Related]
11. High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism.
Marcucci R; Fedi S; Brunelli T; Pepe G; Prisco D; Rosati A; Zanazzi M; Bertoni E; Abbate R; Salvadori M
Transplantation; 2001 Mar; 71(6):746-51. PubMed ID: 11330536
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms.
Fillon-Emery N; Chango A; Mircher C; Barbé F; Bléhaut H; Herbeth B; Rosenblatt DS; Réthoré MO; Lambert D; Nicolas JP
Am J Clin Nutr; 2004 Dec; 80(6):1551-7. PubMed ID: 15585767
[TBL] [Abstract][Full Text] [Related]
13. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
15.
Huang X; Qin X; Yang W; Liu L; Jiang C; Zhang X; Jiang S; Bao H; Su H; Li P; He M; Song Y; Zhao M; Yin D; Wang Y; Zhang Y; Li J; Yang R; Wu Y; Hong K; Wu Q; Chen Y; Sun N; Li X; Tang G; Wang B; Cai Y; Hou FF; Huo Y; Wang H; Wang X; Cheng X
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):679-685. PubMed ID: 29371246
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
[TBL] [Abstract][Full Text] [Related]
17. The methylenetetrahydrofolate reductase 677C-->T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism.
Hustad S; Midttun Ø; Schneede J; Vollset SE; Grotmol T; Ueland PM
Am J Hum Genet; 2007 May; 80(5):846-55. PubMed ID: 17436239
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism of MTHFR C677T, serum vitamin levels and cognition in subjects with hyperhomocysteinemia in China.
Cheng DM; Jiang YG; Huang CY; Kong HY; Pang W; Yang HP
Nutr Neurosci; 2010 Aug; 13(4):175-82. PubMed ID: 20670473
[TBL] [Abstract][Full Text] [Related]
19. Plasma Homocysteine, Serum Folic Acid, Serum Vitamin B12, Serum Vitamin B6, MTHFR, and Risk of Normal-Tension Glaucoma.
Li J; Xu F; Zeng R; Gong H; Lan Y
J Glaucoma; 2016 Feb; 25(2):e94-8. PubMed ID: 26171850
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine-lowering therapy and risk of recurrent stroke, myocardial infarction and death: the impact of age in the VISP trial.
Towfighi A; Arshi B; Markovic D; Ovbiagele B
Cerebrovasc Dis; 2014; 37(4):263-7. PubMed ID: 24751920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
